Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization

Affiliations

• ¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
• ² Department of Oncology/Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
• ³ School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
• ⁴ Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.